13th Annual Board Review and Comprehensive Update
Hematology and Medical Oncology
Comprehensive Board Review & Clinical Update
🎥 Videos
📄 PDFs
Specialties
Hematology, Infectious Diseases, Medical Oncology, Oncology and Hematology,
Radiation Oncology, Surgical Oncology
📚 Course Description
This 13th Annual Board Review and Comprehensive Update in Hematology and Medical Oncology
offers an in-depth and current review of the diagnosis, staging,and management of neoplastic
diseases,encompassing both solid tumors and hematologic malignancies.
Expert-led lectures and discussions cover disease-specific topics across gastrointestinal,
gynecologic, thoracic, ead and neck, genitourinary, soft tissue and skin, and central nervous
system cancers, as well as hematologic malignancies.
This program is designed to support participants in their preparation for the
American Board of Internal Medicine (ABIM) certification and recertification examinations
in Hematology and Medical Oncology and is now avaible on Medustudy website.
🎓 Course Content
🎥 Videos + 📄 PDFs
🧬 Solid Tumors
COLON CANCER
Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center
Leonard Saltz, MD
Executive Director for Clinical Value & Sustainability;
Head, Colorectal Oncology Section;
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical Center
MELANOMA
Michael A. Postow, MD
Chief, Melanoma Service;
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center
Michael A. Postow, MD
Chief, Melanoma Service;
Co-Director, Melanoma Disease Management Team
Memorial Sloan Kettering Cancer Center
KIDNEY CANCER
Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Robert J. Motzer, MD
Section Head, Kidney Cancer;
Jack and Dorothy Byrne Chair in Clinical Oncology;
Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
PROSTATE CANCER
Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs, Department of Medicine;
Attending Physician, Genitourinary Oncology Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
Susan F. Slovin, MD, PhD
Associate Vice Chair, Academic Affairs, Department of Medicine;
Attending Physician, Genitourinary Oncology Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
MESOTHELIOMA
Michael D. Offin, MD
Co-Director, Mesothelioma Program;
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
Michael D. Offin, MD
Co-Director, Mesothelioma Program;
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
UROTHELIAL CANCER
Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Gopa Iyer, MD
Section Head, Bladder Cancer;
Associate Attending Physician, Genitourinary Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
TESTIS CANCER
Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College
Darren R. Feldman, MD
Chair, Quality Assurance;
Section Head, Germ Cell Cancer;
Associate Attending Physician, Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medical College
UTERINE, CERVIX, AND OTHER GYNECOLOGIC CANCERS
Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service;
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center
Carol Aghajanian, MD
Chief, Gynecologic Medical Oncology Service;
Avon Chair in Gynecologic Oncology Research
Memorial Sloan Kettering Cancer Center
OVARIAN CANCER
Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician, Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Rachel N. Grisham, MD
Section Head, Ovarian Cancer;
Director, Gynecologic Medical Oncology, MSK Westchester;
Associate Attending Physician, Gynecologic Medical Oncology Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER SURGERY
Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen;
Assistant Attending Surgeon, Breast Service
Memorial Sloan Kettering Cancer Center
Anita Mamtani, MD, FACS
Surgical Site Director, MSK Bergen;
Assistant Attending Surgeon, Breast Service
Memorial Sloan Kettering Cancer Center
BREAST CANCER RADIATION THERAPY
Lior Z. Braunstein, MD
Associate Attending Radiation Oncologist,
External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center
Lior Z. Braunstein, MD
Associate Attending Radiation Oncologist,
External Beam Radiotherapy Service
Memorial Sloan Kettering Cancer Center
HEREDITARY CANCER GENETICS
Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service & Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Zsofia K. Stadler, MD
Clinical Director, Clinical Genetics Service;
Associate Attending Physician, Clinical Genetics Service & Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
SMALL CELL LUNG CANCER
Alissa J. Cooper, MD
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
Alissa J. Cooper, MD
Assistant Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
HER2-POSITIVE BREAST CANCER
Joshua Z. Drago, MD, MS
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Joshua Z. Drago, MD, MS
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
TRIPLE-NEGATIVE BREAST CANCER
Rachel Sanford, MD
Associate Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Rachel Sanford, MD
Associate Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
HORMONE RECEPTOR-POSITIVE BREAST CANCER
Devika Gajria, MD
Medical Site Director, MSK Bergen;
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
Devika Gajria, MD
Medical Site Director, MSK Bergen;
Assistant Attending Physician, Breast Medicine Service
Memorial Sloan Kettering Cancer Center
CARCINOMA OF UNKNOWN PRIMARY
Anna M. Varghese, MD
Associate Attending Physician,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Anna M. Varghese, MD
Associate Attending Physician,
Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
HEPATOCELLULAR CANCER AND CHOLANGIOCARCINOMA
Ghassan K. Abou-Alfa, MD, JD, MBA
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell College at Cornell University
Adjunct Professor of Medical Diplomacy, Trinity College Dublin
Ghassan K. Abou-Alfa, MD, JD, MBA
Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor, Weill Cornell College at Cornell University
Adjunct Professor of Medical Diplomacy, Trinity College Dublin
PANCREATIC AND NEUROENDOCRINE CANCERS
Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Chair, Human Research Protection Program and Institutional Review Board;
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobi;
Attending Physician, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Eileen M. O’Reilly, MD
Winthrop Rockefeller Endowed Chair in Medical Oncology;
Chair, Human Research Protection Program and Institutional Review Board;
Co-Director, Medical Initiatives, David M. Rubenstein Center for Pancreatic Cancer Research;
Section Head, Hepatopancreaticobi;
Attending Physician, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
NON-SMALL CELL LUNG CANCER
Gregory J. Riely, MD, PhD
Ning Zhao and Ge Li Chair in Lung Cancer Research;
Vice Chair, Clinical Research;
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
Gregory J. Riely, MD, PhD
Ning Zhao and Ge Li Chair in Lung Cancer Research;
Vice Chair, Clinical Research;
Attending Physician, Thoracic Oncology Service
Memorial Sloan Kettering Cancer Center
HEAD AND NECK, THYROID, AND NON-MELANOMA SKIN CANCERS
Lara A. Dunn, MD
Assistant Attending Physician, Head and Neck Oncology Service
Memorial Sloan Kettering Cancer Center
Lara A. Dunn, MD
Assistant Attending Physician, Head and Neck Oncology Service
Memorial Sloan Kettering Cancer Center
ANAL AND RECTAL CANCERS
Andrea Cercek, MD
Section Head, Colorectal Cancer;
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers;
Associate Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Andrea Cercek, MD
Section Head, Colorectal Cancer;
Co-Director, Center for Young Onset Colorectal and Gastrointestinal Cancers;
Associate Attending Physician, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
ESOPHAGEAL AND GASTRIC CANCERS
David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
David H. Ilson, MD, PhD, FACP, FASCO
Attending Physician, Member, Gastrointestinal Oncology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
CENTRAL NERVOUS SYSTEM TUMORS
Thomas J. Kaley, MD
Chief, Neuro-Oncology and Cancer Neurology Service;
Vice Chair for Clinical Research, Department of Neurology;
Chair, Institutional Review Board (IRB-C);
Associate Attending Neuro-Oncologist
Memorial Sloan Kettering Cancer Center
Thomas J. Kaley, MD
Chief, Neuro-Oncology and Cancer Neurology Service;
Vice Chair for Clinical Research, Department of Neurology;
Chair, Institutional Review Board (IRB-C);
Associate Attending Neuro-Oncologist
Memorial Sloan Kettering Cancer Center
SARCOMA
Robert Maki, MD, PhD
Attending Physician, Member, Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Robert Maki, MD, PhD
Attending Physician, Member, Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
INFECTIOUS DISEASE
Susan K. Seo, MD
Director, Antibiotic Management Program;
Attending Physician, Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
Susan K. Seo, MD
Director, Antibiotic Management Program;
Attending Physician, Infectious Disease Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
PHARMACOLOGY I & II
Mrinal M. Gounder, MD
Physician Ambassador, India and Asia;
Associate Attending Physician, Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
Mrinal M. Gounder, MD
Physician Ambassador, India and Asia;
Associate Attending Physician, Sarcoma Medical Oncology Service & Early Drug Development Service
Memorial Sloan Kettering Cancer Center
🩸 Malignant Hematology
ACUTE MYELOID LEUKEMIA
Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
Eytan M. Stein, MD
Chief, Leukemia Service;
Director, Program for Drug Development in Leukemia, Division of Hematologic Malignancies
Memorial Sloan Kettering Cancer Center
LOW-GRADE NON-HODGKIN LYMPHOMA
Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Andrew D. Zelenetz, MD, PhD
Medical Director, Quality Informatics;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
CHRONIC LYMPHOCYTIC LEUKEMIA / SMALL LYMPHOCYTIC LYMPHOMA
Meghan C. Thompson, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
Meghan C. Thompson, MD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
DIFFUSE LARGE B-CELL LYMPHOMA / MANTLE CELL LYMPHOMA / BURKITT LYMPHOMA
Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
Paul A. Hamlin, MD
Medical Director, David H. Koch Center for Cancer Care;
Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Professor of Clinical Medicine, Weill Cornell Medical College
HODGKIN LYMPHOMA / T CELL
Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
Alison J. Moskowitz, MD
Associate Attending Physician, Lymphoma Service
Memorial Sloan Kettering Cancer Center
AUTO / ALLO
Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
Gunjan L. Shah, MD
Assistant Attending Physician, Bone Marrow Transplant Service & Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
CAR T CELLS
Craig Sauter, MD
Director, Blood and Marrow Transplant Program
Cleveland Clinic
Craig Sauter, MD
Director, Blood and Marrow Transplant Program
Cleveland Clinic
ACUTE LYMPHOCYTIC LEUKEMIA
Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Adult Lymphoblastic Leukemia Program Leader;
Assistant Attending Physician, Leukemia Service;
Chair, Quality Assessment, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
Mark B. Geyer, MD
Adolescent and Young Adult Program Leader;
Adult Lymphoblastic Leukemia Program Leader;
Assistant Attending Physician, Leukemia Service;
Chair, Quality Assessment, Cellular Therapy Service
Memorial Sloan Kettering Cancer Center
MYELOPROLIFERATIVE NEOPLASMS
Raajit K. Rampal, MD, PhD
Director, Center for Hematologic Malignancies;
Director, Myeloproliferative Neoplasms Program;
Associate Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
Raajit K. Rampal, MD, PhD
Director, Center for Hematologic Malignancies;
Director, Myeloproliferative Neoplasms Program;
Associate Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
MYELODYSPLASTIC
Aaron D. Goldberg, MD, PhD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
Aaron D. Goldberg, MD, PhD
Assistant Attending Physician, Leukemia Service
Memorial Sloan Kettering Cancer Center
CHRONIC MYELOGENOUS LEUKEMIA
Michael J. Mauro, MD
Attending Physician, Member, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Michael J. Mauro, MD
Attending Physician, Member, Leukemia Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
MYELOMA / AMYLOID
Malin Hultcrantz, MD, PhD
Assistant Attending Physician, Myeloma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medicine
Malin Hultcrantz, MD, PhD
Assistant Attending Physician, Myeloma Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Medicine, Weill Cornell Medicine
🩺 Benign Blood Disorders
APPROACH TO THE BLEEDING PATIENT
Avi Leader, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Avi Leader, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
THROMBOTIC DISORDERS
Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
Jeffrey Zwicker, MD
Chief, Hematology Service
Memorial Sloan Kettering Cancer Center
Professor of Medicine, Weill Cornell Medical College
ANTITHROMBOTIC AND ANTIPLATELET THERAPY
Simon Mantha, MD, MPH
Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Simon Mantha, MD, MPH
Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
THROMBOCYTOPENIA AND ITP
Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Cy R. Wilkins, MD
Assistant Attending Physician, Hematology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
SICKLE CELL DISEASE, THALASSEMIA
Susanna Curtis, MD, PhD
Assistant Professor of Medicine, Hematology and Medical Oncology;
Assistant Director, The Mount Sinai Comprehensive Sickle Cell Program
Icahn School of Medicine at Mount Sinai
Susanna Curtis, MD, PhD
Assistant Professor of Medicine, Hematology and Medical Oncology;
Assistant Director, The Mount Sinai Comprehensive Sickle Cell Program
Icahn School of Medicine at Mount Sinai
HEMOLYTIC ANEMIA
Gerald A. Soff, MD
Chief, Classical Hematology Service
University of Miami Health System / Sylvester Comprehensive Cancer Center
Soffer Clinical Research Building
Gerald A. Soff, MD
Chief, Classical Hematology Service
University of Miami Health System / Sylvester Comprehensive Cancer Center
Soffer Clinical Research Building
CLINICAL INDICATIONS FOR USE OF BLOOD PRODUCTS AND ASSOCIATED RISKS
P. Dayand Borge, MD, PhD
Chief, Transfusion Medicine and Cell Therapy Service
Memorial Sloan Kettering Cancer Center
P. Dayand Borge, MD, PhD
Chief, Transfusion Medicine and Cell Therapy Service
Memorial Sloan Kettering Cancer Center
TRANSFUSION REACTIONS
13th Annual Board Review and Comprehensive Update
Hematology and Medical Oncology
🎥 Videos | 📄 PDFs
Comprehensive review for Hematology and Medical Oncology board preparation
Reviews
There are no reviews yet.